The ERG rearrangement is highly specific to PCa (30), is maintained in advanced disease (2,31), and depending on the cohort design and the histological subtypes of PCa (20,32–34) approximately 15–80% of PCa patients harbour the TMPRSS2-ERG fusions (2–4,35,36). Here, TMPRSS2 is linked to posterior cortical atrophy.